In mouse xenograft models of glioma, pleural mesothelioma, and ovarian and colorectal cancers, the tumor load was reduced and the effector function of CAR T cells was much improved after PD-1 gene disruption [13,14]. The gene discussed is PDCD1; the disease is central nervous system cancer.